Background: Limited data exist on the incidence and outcome of early infection after orthotopic heart transplantation (OHT). The purpose of this study was to describe characteristics and outcomes of OHT recipients with an early infection and to identify predictors of such infections. Methods: This retrospective, single-center study included patients greater than 18 years of age who underwent OHT from February 2009 to May 2014 and had an infection within 30 days of transplantation. Patient demographics, clinical variables, and outcomes were collected. Multivariable logistic regression was performed to identify independent predictors of infection. Results: Of the 172 eligible OHT recipients, 51 (29.7%) had an early infection. The median time to diagnosis was five days, with gram-negative organisms being slightly more common (58.2%). No differences in mortality rate, rejection, or re-admission were found between the groups. Longer durations of mechanical ventilation and lengths of stay were found in the infection group (p < 0.001). Patients with an early infection also had a higher incidence of mechanical circulatory support, history of drive-line infection, longer duration of mechanical ventilation, continuous renal replacement therapy (CRRT), and delayed chest closure (p < 0.05 for all). Pre-OHT left-ventricular assist device (adjusted odds ratio [AOR] 2.53; 95% confidence interval [CI] 1.015-6.286; p < 0.046), pre-OHT extracorporeal membrane oxygenation (AOR 14.10; 95% CI 1.38-150.5; p = 0.026) and post-OHT CRRT (AOR 3.98; 95% CI 1.67-9.52; p = 0.002) were found to be independent risk factors for an early infection. A total of 90% of the available susceptibility panels for the gram-negative isolates (26/29) were resistant to the standard peri-operative cephalosporin given. Conclusions: Prior mechanical circulatory support and the acute need for CRRT may predispose OHT patients to an infection early in the post-operative period. Evaluation of peri-operative antimicrobial prophylaxis, based on an individual center's resistance panels, may be warranted.
S
ince the first heart transplantation in 1967, the procedure has grown worldwide to a total of 120,991 adult recipients as of June 2016 [1] . With advances in immunosuppression regimens and surgical technique, the overall risk of rejection and survival have improved [2, 3] . However, infectious complications remain and may influence survival, rejection, and re-admission rates.
According to the Scientific Registry of Transplant Recipients (SRTR) and Organ Procurement and Transplantation Network (OPTN) Annual Data Report in 2015, infection was the most common cause of death (2.3% of the series) at one year after OHT [2] . Infection within the first month post-OHT has demonstrated even higher mortality rates (13%-60%) in some studies [4, 5] . Bacterial infections continue to be the most common type of severe infections [4, [6] [7] [8] [9] , with gram-positive organisms being the primary infecting pathogens [6] . Interest in blactamase-producing Enterobacteriaceae and fungal infections in this patient population also has emerged recently [10] [11] [12] .
Although the incidence and type of infection post-OHT have been reported [1, 2, 4, 5] , the characteristics of patients who develop infection in the early transplant period have not been described well. Descriptions of the organisms cultured, sites of infection, and risk factors contributing to these early infections are lacking. Additionally, the impact of early infection on clinical outcomes is unclear. The purpose of this study was to describe the characteristics and outcomes of OHT recipients with an infection identified within 30 days of transplantation. Secondary objectives were identifying factors associated with an early infection.
Patients and Methods
This retrospective, single-center cohort study was performed at Barnes-Jewish Hospital, a 1,315-bed tertiary-care academic medical center that is the affiliated teaching hospital for Washington University School of Medicine in St. Louis. The Washington University School of Medicine Human Research Protection Office and the Protocol Review and Monitoring Committee approved this study.
The Barnes-Jewish Hospital medical informatics system was queried to identify OHT recipients who were admitted between February 2009 and May 2014. To be included in the earlyinfection cohort, OHT recipients had to be at least 18 years of age, have a positive culture with one or more organism(s), and meet the specified definition of infection within 30 days posttransplant. Exclusion criteria included death within 48 hours of transplant, missing data in the medical chart, transplant performed at an outside hospital, or active infection requiring intravenous antibiotics at the time of transplantation.
Electronic medical records were searched to identify demographic data, immunosuppressive and antimicrobial regimens received, site of positive culture(s), organism(s) cultured, and time to first positive culture. Baseline comorbidities were identified via the International Classification of Disease 9 th revision codes [13, 14] . Hospital and intensive care unit (ICU) length of stay (LOS), rejection occurrence, re-admission dates, and mortality data also were collected.
Definitions
All documented infections were confirmed on the basis of clinical signs and symptoms of infection in correlation with a positive culture and an infectious disease consultation when applicable. Pneumonia was defined as the presence of new or worsening radiographic pulmonary infiltrates along with clinical findings suggesting infection (leukocytosis, fever, purulent sputum) in addition to growth of organism(s) in cultures obtained through sputum or tracheal aspirate, with hospital-acquired pneumonia (HAP) occurring 48 hours or more after admission and ventilator-associated pneumonia (VAP) occurring 48 hours or more after endotracheal intubation. Nosocomial tracheobronchitis was defined when clinical findings suggested a pulmonary infection with a positive respiratory culture without a new lung infiltrate [4, 15] . Urinary tract infection (UTI) was diagnosed in patients without an indwelling urethral catheter when documentation of pyuria or bacteremia in addition to a positive urine culture (>10 5 colony-forming units [CFU]/mL) was found [4] . In patients with indwelling urethral catheters, ‡10 5 CFU/mL of one or more bacterial species in a urine specimen had to be noted [16] . Blood stream infection (BSI) was defined as one or more organisms isolated from at least two consecutive blood cultures. In cases involving microorganisms of doubtful significance (e.g., Bacillus spp., coagulase-negative Staphylococcus spp.), clinically relevant episodes were noted only if evidence of clinical infection was present in addition to an infectious disease consultation diagnosis.
Multi-drug resistance (MDR) for Staphylococcus aureus, Enterococcus spp., Enterobacteriaceae, Pseudomonas aeruginosa, and Acinetobacter spp. were defined according to standardized terminology [17] . Our institution's microbiology laboratory reports susceptibility results of AmpC-stable blactamases as well as non-b-lactam agents for Enterobacter spp., Serratia spp., and Citrobacter freundii. Default resistance to AmpC-labile agents (ceftriaxone, aztreonam, piperacillin/ tazobactam) is reported for the aforementioned bacterial isolates, as at our center, 85% have inducible AmpC resistance and 11% have stable high-level AmpC expression [18] .
Appropriate antimicrobial therapy was defined as an initially prescribed regimen with activity against the identified pathogen based on in vitro susceptibility testing and administration within 24 hours of culture. Acute cellular rejection (ACR) was defined as a biopsy specimen post-OHT displaying Grade ‡2R/3a rejection [19] .
Standard process of care
Peri-operative prophylaxis for OHT recipients includes vancomycin and cefazolin intra-operatively, continued for 24 hours after chest closure. Heart transplant recipients at our institution do not receive routine surveillance cultures in the intra-operative or post-operative periods. 
Statistical analysis
Statistical analysis was completed using SPSS software, version 22.0 (SPSS, Inc., Chicago, IL). Continuous data were analyzed using the Student's t-test for parametric data and the Mann-Whitney U test for nonparametric data. Categorical data were analyzed with the w 2 or the Fisher exact test. A p value <0.05 was considered significant. Backwards stepwise logistic regression was utilized to identify risk factors independently associated with an early infection. Variables significant at a p value £0.1 in the univariable analyses were INFECTION AFTER HEART TRANSPLANTATION 517 entered in the stepwise multivariable logistic regression model.
Results
A total of 185 OHTs were performed during the study period. Thirteen patients were excluded, leaving 172 patients for analysis. Early infection criteria were met in 51 patients (29.7%) (Fig. 1 ). The majority of the patients were Caucasian males, younger than 65 years, with an idiopathic cardiomyopathy diagnosis. A significantly higher percent of patients in the early infection cohort received extracorporeal membrane oxygenation (ECMO) before OHT (11.8% vs. 0.8%; p = 0.003), were left-ventricular assist device (LVAD) explants (66.7% vs. 30.6%; <0.001), and had histories of driveline infection (23.5% vs. 10.7%; p = 0.035) ( Table 1 ). When further analyzed by type of infection, no differences in demographic data were found.
No difference in induction therapy was noted between the early-infection and no early-infection cohorts. The primary agent utilized was basiliximab in both groups. All patients received maintenance therapy with tacrolimus, MMF, and steroids per protocol. Patients in the infection cohort had a higher incidence of continuous renal replacement therapy (CRRT) after OHT, delayed chest closure, ECMO after OHT, and a longer duration of mechanical ventilation (p < 0.05) ( Table 2) .
Early infection cohort
The median temperature at the time of infection diagnosis was 37.3°C (interquartile range [IQR] 36.6-37.9°C). Of note, 24 patients (47%) were on CRRT at the time of their infection diagnosis, potentially masking the presence of a fever. The median white blood cell (WBC) count at the time of infection diagnosis was 23 · 10 A total of 67 organisms were identified in the 51 patients with an early infection ( Table 3 ). The most prevalent organisms were gram-negative bacteria (n = 39; 58.2%) with fewer gram-positive organisms (n = 20; 29.9%). The most common organisms were Staphylococcus spp., Enterobacter spp., and Escherichia coli. Twenty-four MDR pathogens (47%) were identified (20 gram-negative, two methicillinresistant S. aureus, two vancomycin-resistant Enterococci).
The most prevalent infection was pneumonia (n = 24; 47%; 19 VAP, five HAP) followed by BSI (n = 0; 19.6%) and UTI (n = 7; 13.7%). Other infections were ventricular-assist device (VAD) pocket (n = 3; 5.8%), tracheobronchitis (n = 2; 3.9%), Clostridium difficile diarrhea (n = 2), and mediastinitis, groin seroma, pericarditis, and pacemaker (n = 1 each; 2.0%). Of the 24 pneumonia episodes, the organisms most often isolated were gram-negative species with a median time to infection of 4.3 days. Of note, patients with pneumonia had a longer median mechanical ventilation duration of 9.5 (IQR 5.4-15.7) days compared with 2.8 (IQR 0.7-5.1) days in the patients with other sites of infection (p < 0.001). Additionally, the median mechanical ventilation duration for patients with pneumonia was significantly longer than for the non-infected group (9.5 vs. 1.8 days; IQR 0.8-3.6 days; p < 0.0001). The most common BSI organisms were Serratia marcescens (n = 3; 30%) and Enterobacter cloacae (n = 2; 20%) with a median time to infection of 5.3 days. Escherichia coli and Pseudomonas aeruginosa (n = 2; 28.6% each) were the most common UTI organisms with a median time to infection of nine days. The median duration of mechanical ventilation prior to a diagnosis of a non-respiratory infection was four days. This was not significantly different from those with a respiratory infection.
Antimicrobial therapy
Standard peri-operative antimicrobial prophylaxis was administered to 75% of patients who sustained an early infection when patient allergies or previous culture history did not cause divergence. The remaining 25% received broader coverage with linezolid in the case of vancomycin intolerance and aztreonam or meropenem for cephalosporin intolerance. Of the 33 patients with gram-negative isolates, 29 (88%) had susceptibility panels available for assessment. Notably, a total of 26 (90%) of the available susceptibility panels for the gram-negative isolates, which included Citrobacter freundii, Enterobacter spp., Escherichia coli, Klebsiella pneumoniae, Proteus spp., Pseudomonas aeruginosa, and Serratia marcescens, showed resistance to cefazolin. The median time to FIG. 1. Adult orthotopic heart transplant (OHT) recipients from Barnes-Jewish Hospital were assessed for study inclusion. Based on the inclusion criteria, 172 patients were eligible for analysis, with 51 patients meeting the criteria for early infection. positive culture in this group was 1.5 days. Overall, inappropriate antimicrobial treatment was noted in 12 patients (24%).
Outcomes
No differences in the mortality rate at 30 days or one year were found. The median time to death was shorter in the infection cohort although not significantly so (41.6 vs. 470 days; p = 0.23). Three patients in the early infection group died prior to hospital discharge as a result of sepsis (n = 2) or primary graft dysfunction (PGD) (n = 1). One patient in the no-infection group died of PGD. Rejection rates were similar in the two groups. Patients with an early infection had a longer ICU and hospital LOS (p < 0.001). No differences in 30-day re-admission rate were found (Table 4) .
Risk Factors for Early Infection
The following variables in the univariable analyses with a p value <0.1 were entered in a backwards stepwise logistical regression analysis: LVAD (with and without drive-line infection), ECMO (pre-and post-OHT), delayed chest closure, and CRRT. This analysis revealed that that pre-OHT LVAD (Table 5 ). Further analysis assessing the impact of a prior LVAD on the development of an infection was performed. No significant differences in the number of pneumonia, BSI, UTI, or wound infections were found in patients with and without a LVAD.
Discussion
This study provides insight into the characteristics of OHT recipients with an early infection. The incidence of early infection found in this study (29.7%) is lower than that in previous reports of infection within 30 days of heart transplantation (48.6%), likely due to the requirement of a positive culture for inclusion in our study [7] . Although gram-positive bacteria have been the primary cause of infections in this patient population historically, one study assessing more than 600 heart transplant recipients noted a P. aeruginosa infection rate as high as 43%, with the most common site of infection being the lungs (35%) [4] . Similarly, gram-negative organisms comprised the majority of the isolates in our study (58.2%), with the lungs being the most prevalent site of infection. Gram-positive infection still was prevalent (30%) followed by fungal infection (9%). Significantly, MDR pathogens were present in 47% of patients. Extendedspectrum ESBL-producing gram-negative organisms have been reported in 2.2% of heart transplant recipients [12] , whereas we noted two ESBL infections (3.9%).
The median time to early infection was less than a week in our study, with lung infections prevailing at a median of five days and blood cultures at a median of 1.5 days. In fact, all patients but one met the infection criteria within 14 days of transplant, suggesting this is the most critical time period to prevent post-OHT infection. Montoya et al. [4] report median times for infectious episodes to be 28 days for mediastinal incisions, 48 days for bacteremia, and 65 days for pneumonia. The differences may be attributable to the large percentage of pre-OHT mechanical circulatory support in our study, as the infection risks in this patient population are well known.
Our mortality rate in the early post-transplantation period was less than 5% and was not different at one year, similar to the findings in other published reports [2, 8] . Although the difference was not statistically significant, it should be recognized that the 30-day mortality rate was 4% in the infection cohort and 0.8% in the no-infection cohort. The likelihood of a Type II error in testing this difference is high. In addition, rejection and re-admission were similar in the two groups. Mechanical ventilation duration and LOS were longer in the infection cohort; however, it remains unknown whether this was a consequence of or a risk factor for infection. It is intuitive to think that patients with pneumonia will require longer mechanical ventilation. Likewise, patients with any infection may have a longer LOS, with the assumption that they have a greater severity of illness requiring longer treatment and monitoring. Regardless, we were unable to establish causality between these important factors.
Predictors of an early infection in our study included the use of mechanical circulatory support and the need for acute CRRT. Induction immunosuppression, renal replacement therapy, delayed chest closure, and the use of ECMO have been associated with a possible increase in the risk of fungal infections in OHT recipients [11, 12] . However, these studies were small and do not addresses whether these factors place patients at risk for other bacterial infections [10, 11, 21] Previous LVAD-related infections have been noted to put patients at risk for more invasive infections after OHT, with continuous antimicrobial treatment before, during, and after transplantation being associated with fewer relapses [20] . In our study, more patients in the infection group had histories of drive-line infections, but this did not remain a predictor of infection by logistic regression analysis. This finding may suggest that the presence of an LVAD alone (with or without a previous infection) is a risk factor for post-OHT infection. Although delayed chest closure did not remain a predictor of infection in our study, it is worth noting that fungal infections occurred in only three of these patients, whereas gram-negative infections (72%) prevailed. The three patients with delayed chest closure who developed a fungal BSI (within 10-16 days) were all LVAD explants, with one receiving chronic suppressive antibiotics for a median of 80 weeks. Although this may be important, because of the limited number of fungal infections and study design limitations, we are unable to make definitive recommendations on anti-fungal prophylaxis. However, known risk factors for fungal infection, such as long-term receipt of antibiotics [22] , should be considered when deciding on prophylaxis in this patient population. Regarding routine antibiotic prophylaxis, it is worth noting that in our study, 90% of the susceptibility panels for the gram-negative isolates showed resistance to our standard intra-operative and perioperative prophylaxis cephalosporin, cefazolin. Accordingly, the median time to positive culture in this group experiencing resistance was less than two days. A broader-spectrum cephalosporin with adequate in vitro activity against the most common organisms cultured, such as cefepime, may be warranted in the early transplant period in these high-risk populations. Non-cephalosporin alternatives such as carbapenems may be appropriate at centers with higher rates of ESBLproducing organisms. Likewise, centers with lower rates of AmpC-producing organisms may desire to use b-lactamaseinhibiting agents, such as piperacillin/tazobactam.
There are several limitations of this study. This was a retrospective cohort investigation and suffers from the potential biases inherent to this design. The interpretation of positive culture significance, therapeutic management, and patient outcome depends on the accuracy of the documentation. Additionally, patients treated for culture-negative sepsis or suspected clinical infections were not included. The majority of the positive cultures were identified during the patient's stay in the ICU, and the incidence and impact of an early positive culture outside of an ICU remains unknown. Furthermore, the frequency and timing of any previously treated infections was not assessed. It remains unknown if prior infections, outside of chronic drive-line infections, increased the risk of post-OHT infection in this study. In addition, the impact of nasogastric tube application and receipt of enteral nutrition on the occurrence of pneumonia infections could not be assessed. Finally, as this study was conducted at a single institution, the results may not be applicable to other institutions.
In conclusion, this study has provided additional descriptions of the OHT patient population with an infection in the early post-operative period. Gram-negative organisms accounted for the majority of isolates, with most common sites of infection being the lungs and blood. Although no statistically significant differences in overall mortality, rejection, or re-admission rates were seen, a longer LOS and duration of mechanical ventilation were found in patients with an early infection. The relative difference in the 30-day mortality rate may support a modified approach to preventing infection in higher-risk patients. Previous mechanical support and the need for acute CRRT may place heart transplant recipients at risk for an early infection. Evaluation of peri-operative antimicrobial prophylaxis duration and selection based on an individual center's resistance panels may be warranted in these patients. Hosmer-Lemes p = 0.99. AOR = adjusted odds ratio; CI = confidence interval; CRRT = continuous renal replacement therapy; ECMO = extracorporeal membrane oxygenation; LVAD = left-ventricular assist device; OHT = orthotopic heart transplantation.
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